| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.22 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |